These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10715410)

  • 21. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
    Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
    Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody.
    Pearson TC; Madsen JC; Larsen CP; Morris PJ; Wood KJ
    Transplantation; 1992 Sep; 54(3):475-83. PubMed ID: 1384183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
    Qin L; Ding Y; Tahara H; Bromberg JS
    J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies.
    Moffatt SD; Metcalfe SM
    Transplant Proc; 1999 Nov; 31(7):2740. PubMed ID: 10578271
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness.
    Saitovitch D; Bushell A; Mabbs DW; Morris PJ; Wood KJ
    Transplantation; 1996 Jun; 61(11):1642-7. PubMed ID: 8669111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of alloantigen-specific CD4+ T regulatory Type 1 cells by alloantigen immunization and ultraviolet-B irradiation: a pilot study in murine transplantation models with skin and cardiac allografts.
    Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
    Ann Transplant; 2014 Oct; 19():519-36. PubMed ID: 25322948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FK 506 abrogates induction of regulatory cells after intratracheal delivery of alloantigen.
    Shibutani S; Akiyama Y; Shirasugi N; Matsumoto K; Kitajima M; Aramaki O; Yokoyama T; Kan S; Ikeda Y; Niimi M
    Transplant Proc; 2002 Aug; 34(5):1445. PubMed ID: 12176432
    [No Abstract]   [Full Text] [Related]  

  • 28. Mice treated with anti-CD4 monoclonal antibody accept fully allogeneic thyroid grafts but reject second-donor-type thyroid grafts in maintenance phase.
    Niimi M; Takashina M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Kameyama K; Matsumoto K; Hamano K; Esato K
    Transplant Proc; 2000 Nov; 32(7):2086. PubMed ID: 11120078
    [No Abstract]   [Full Text] [Related]  

  • 29. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
    Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
    Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of alloantigen-reactive thymocytes as a mechanism of adult tolerance induction following intrathymic antigen administration.
    Jones ND; Fluck NC; Roelen DL; Mellor AL; Morris PJ; Wood KJ
    Eur J Immunol; 1997 Jul; 27(7):1591-600. PubMed ID: 9247566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness.
    Saitovitch D; Bushell AR; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):117-8. PubMed ID: 7878834
    [No Abstract]   [Full Text] [Related]  

  • 32. Spleen plays an important role in maintaining tolerance after removal of the vascularized heart graft.
    Chosa E; Hara M; Watanabe A; Matsuzaki Y; Nakamura K; Hamano K; Wood KJ; Onitsuka T
    Transplantation; 2007 May; 83(9):1226-33. PubMed ID: 17496540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
    Onodera K; Lehmann M; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997 May; 29(3):1907-8. PubMed ID: 9142316
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy.
    Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG
    Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts.
    Jaques BC; Ahmiedat H; Alastair Gracie J; Marshall HE; Middleton SE; Bolton EM; Bradley JA
    Transplantation; 1998 Nov; 66(10):1291-9. PubMed ID: 9846511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
    Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ
    J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.